Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Eli Lilly and Company · 2004
ClinicalTrials.gov · Datasets · License: Public Domain · 2004
Open Source ↗
attention deficit disorder with hyperactivity, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 889305
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.